A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
- 27 December 2013
- journal article
- video audio-media
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 82,p. e50908
Abstract
Botulinum neurotoxin (BoNT) is a potent and potentially lethal bacterial toxin that binds to host motor neurons, is internalized into the cell, and cleaves intracellular proteins that are essential for neurotransmitter release. BoNT is comprised of a heavy chain (HC), which mediates host cell binding and internalization, and a light chain (LC), which cleaves intracellular host proteins essential for acetylcholine release. While therapies that inhibit toxin binding/internalization have a small time window of administration, compounds that target intracellular LC activity have a much larger time window of administrations, particularly relevant given the extremely long half-life of the toxin. In recent years, small molecules have been heavily analyzed as potential LC inhibitors based on their increased cellular permeability relative to larger therapeutics (peptides, aptamers, etc.). Lead identification often involves high-throughput screening (HTS), where large libraries of small molecules are screened based on their ability to modulate therapeutic target function. Here we describe a FRET-based assay with a commercial BoNT/A LC substrate and recombinant LC that can be automated for HTS of potential BoNT inhibitors. Moreover, we describe a manual technique that can be used for follow-up secondary screening, or for comparing the potency of several candidate compounds.Keywords
This publication has 21 references indexed in Scilit:
- Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors through Rational DesignACS Chemical Neuroscience, 2011
- Catalytic Properties of Botulinum Neurotoxin Subtypes A3 and A4Biochemistry, 2009
- Tandem fluorescent proteins as enhanced FRET-based substrates for botulinum neurotoxin activityToxicon, 2009
- The Strange Case of the Botulinum Neurotoxin: Using Chemistry and Biology to Modulate the Most Deadly PoisonAngewandte Chemie International Edition, 2008
- Synthesis, Characterization and Development of a High-Throughput Methodology for the Discovery of Botulinum Neurotoxin A InhibitorsJournal of Combinatorial Chemistry, 2006
- Fluorigenic Substrates for the Protease Activities of Botulinum Neurotoxins, Serotypes A, B, and FApplied and Environmental Microbiology, 2003
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1′ binding subsiteFEBS Letters, 1998
- Endoproteinase Activity of Type A Botulinum Neurotoxin: Substrate Requirements and Activation by Serum AlbuminThe Protein Journal, 1997
- Proteolysis of synthetic peptides by type A botulinum neurotoxinThe Protein Journal, 1995